MEDMEN STOCK FAIL KILLS PHARMA-CANN DEAL
GETTY IMAGES
Poor performance by pot stocks led to the scuttling of MedMen’s plan to purchase Illinois-based PharmaCann. The surprise announcement came only a month after the Department of Justice granted Culver City-based MedMen antitrust approval for the deal. Bloomberg
- When this all-stock deal as announced at this time last year, MedMen was trading . . .
Log in or become a WeedWeek Member to read this article.
